295 related articles for article (PubMed ID: 15967096)
1. The tyrosine kinase pyk2 promotes migration and invasion of glioma cells.
Lipinski CA; Tran NL; Menashi E; Rohl C; Kloss J; Bay RC; Berens ME; Loftus JC
Neoplasia; 2005 May; 7(5):435-45. PubMed ID: 15967096
[TBL] [Abstract][Full Text] [Related]
2. Involvement of ROS-alpha v beta 3 integrin-FAK/Pyk2 in the inhibitory effect of melatonin on U251 glioma cell migration and invasion under hypoxia.
Xu CS; Wang ZF; Huang XD; Dai LM; Cao CJ; Li ZQ
J Transl Med; 2015 Mar; 13():95. PubMed ID: 25889845
[TBL] [Abstract][Full Text] [Related]
3. Differential role of proline-rich tyrosine kinase 2 and focal adhesion kinase in determining glioblastoma migration and proliferation.
Lipinski CA; Tran NL; Bay C; Kloss J; McDonough WS; Beaudry C; Berens ME; Loftus JC
Mol Cancer Res; 2003 Mar; 1(5):323-32. PubMed ID: 12651906
[TBL] [Abstract][Full Text] [Related]
4. Pyk2 and Src-family protein-tyrosine kinases compensate for the loss of FAK in fibronectin-stimulated signaling events but Pyk2 does not fully function to enhance FAK- cell migration.
Sieg DJ; Ilić D; Jones KC; Damsky CH; Hunter T; Schlaepfer DD
EMBO J; 1998 Oct; 17(20):5933-47. PubMed ID: 9774338
[TBL] [Abstract][Full Text] [Related]
5. Involvement of proline-rich tyrosine kinase 2 in platelet activation: tyrosine phosphorylation mostly dependent on alphaIIbbeta3 integrin and protein kinase C, translocation to the cytoskeleton and association with Shc through Grb2.
Ohmori T; Yatomi Y; Asazuma N; Satoh K; Ozaki Y
Biochem J; 2000 Apr; 347(Pt 2):561-9. PubMed ID: 10749687
[TBL] [Abstract][Full Text] [Related]
6. Focal adhesion kinase-related nonkinase inhibits vascular smooth muscle cell invasion by focal adhesion targeting, tyrosine 168 phosphorylation, and competition for p130(Cas) binding.
Koshman YE; Chu M; Engman SJ; Kim T; Iyengar R; Robia SL; Samarel AM
Arterioscler Thromb Vasc Biol; 2011 Nov; 31(11):2432-40. PubMed ID: 21852560
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of PYK2-induced actin cytoskeleton reorganization, PYK2 autophosphorylation and focal adhesion targeting by FAK.
Du QS; Ren XR; Xie Y; Wang Q; Mei L; Xiong WC
J Cell Sci; 2001 Aug; 114(Pt 16):2977-87. PubMed ID: 11686301
[TBL] [Abstract][Full Text] [Related]
8. Microglia Activate Migration of Glioma Cells through a Pyk2 Intracellular Pathway.
Rolón-Reyes K; Kucheryavykh YV; Cubano LA; Inyushin M; Skatchkov SN; Eaton MJ; Harrison JK; Kucheryavykh LY
PLoS One; 2015; 10(6):e0131059. PubMed ID: 26098895
[TBL] [Abstract][Full Text] [Related]
9. The Pyk2 FERM domain as a target to inhibit glioma migration.
Loftus JC; Yang Z; Tran NL; Kloss J; Viso C; Berens ME; Lipinski CA
Mol Cancer Ther; 2009 Jun; 8(6):1505-14. PubMed ID: 19509258
[TBL] [Abstract][Full Text] [Related]
10. Paxillin binding to the alpha 4 integrin subunit stimulates LFA-1 (integrin alpha L beta 2)-dependent T cell migration by augmenting the activation of focal adhesion kinase/proline-rich tyrosine kinase-2.
Rose DM; Liu S; Woodside DG; Han J; Schlaepfer DD; Ginsberg MH
J Immunol; 2003 Jun; 170(12):5912-8. PubMed ID: 12794117
[TBL] [Abstract][Full Text] [Related]
11. Induction of proline-rich tyrosine kinase 2 activation-mediated C6 glioma cell invasion after anti-vascular endothelial growth factor therapy.
Xu CS; Wang ZF; Dai LM; Chu SH; Gong LL; Yang MH; Li ZQ
J Transl Med; 2014 May; 12():148. PubMed ID: 24884636
[TBL] [Abstract][Full Text] [Related]
12. Tyrosine phosphorylation of PYK2 mediates heregulin-induced glioma invasion: novel heregulin/HER3-stimulated signaling pathway in glioma.
van der Horst EH; Weber I; Ullrich A
Int J Cancer; 2005 Feb; 113(5):689-98. PubMed ID: 15499613
[TBL] [Abstract][Full Text] [Related]
13. Different modes and qualities of tyrosine phosphorylation of Fak and Pyk2 during epithelial-mesenchymal transdifferentiation and cell migration: analysis of specific phosphorylation events using site-directed antibodies.
Nakamura K; Yano H; Schaefer E; Sabe H
Oncogene; 2001 May; 20(21):2626-35. PubMed ID: 11420674
[TBL] [Abstract][Full Text] [Related]
14. Pyk2 and FAK differentially regulate progression of the cell cycle.
Zhao J; Zheng C; Guan J
J Cell Sci; 2000 Sep; 113 ( Pt 17)():3063-72. PubMed ID: 10934044
[TBL] [Abstract][Full Text] [Related]
15. Focal adhesion kinase-related proline-rich tyrosine kinase 2 and focal adhesion kinase are co-overexpressed in early-stage and invasive ErbB-2-positive breast cancer and cooperate for breast cancer cell tumorigenesis and invasiveness.
Behmoaram E; Bijian K; Jie S; Xu Y; Darnel A; Bismar TA; Alaoui-Jamali MA
Am J Pathol; 2008 Nov; 173(5):1540-50. PubMed ID: 18832579
[TBL] [Abstract][Full Text] [Related]
16. Extended survival of Pyk2 or FAK deficient orthotopic glioma xenografts.
Lipinski CA; Tran NL; Viso C; Kloss J; Yang Z; Berens ME; Loftus JC
J Neurooncol; 2008 Nov; 90(2):181-9. PubMed ID: 18648907
[TBL] [Abstract][Full Text] [Related]
17. Expression of tyrosine kinases FAK and Pyk2 in 331 human astrocytomas.
Gutenberg A; Brück W; Buchfelder M; Ludwig HC
Acta Neuropathol; 2004 Sep; 108(3):224-30. PubMed ID: 15221336
[TBL] [Abstract][Full Text] [Related]
18. Critical role of the FERM domain in Pyk2 stimulated glioma cell migration.
Lipinski CA; Tran NL; Dooley A; Pang YP; Rohl C; Kloss J; Yang Z; McDonough W; Craig D; Berens ME; Loftus JC
Biochem Biophys Res Commun; 2006 Oct; 349(3):939-47. PubMed ID: 16962067
[TBL] [Abstract][Full Text] [Related]
19. Suppression of store-operated Ca
Zhu M; Lv B; Ge W; Cui Z; Zhao K; Feng Y; Yang X
Cell Cycle; 2020 Dec; 19(24):3468-3479. PubMed ID: 33269647
[TBL] [Abstract][Full Text] [Related]
20. Proline-rich tyrosine kinase 2 and focal adhesion kinase are involved in different phases of platelet activation by vWF.
Canobbio I; Lova P; Sinigaglia F; Balduini C; Torti M
Thromb Haemost; 2002 Mar; 87(3):509-17. PubMed ID: 11916084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
